Male LUTS, OAB, Sex: natural history. JR Sathiya

Similar documents
Prevalence, Severity, and Symptom Bother of Lower Urinary Tract Symptoms among Men in the EPIC Study: Impact of Overactive Bladder

Diagnostic approach to LUTS in men. Prof Dato Dr. Zulkifli Md Zainuddin Consultant Urologist / Head Of Urology Unit UKM Medical Center

VOIDING DYSFUNCTION IN ELDERLY MALE CURRENT STATUS

NOTE: This policy is not effective until April 1, Transurethral Water Vapor Thermal Therapy of the Prostate

Benign Prostatic Hyperplasia (BPH):

NIH Public Access Author Manuscript J Urol. Author manuscript; available in PMC 2010 May 4.

Key words: Lower Urinary Tract Symptoms (LUTS), Prostatic Hyperplasia, Alpha-1 Adrenoceptor Antagonists, Tamsulosin, Terazosin.

50% of men. 90% of men PATIENT FACTSHEET: BPH CONDITION AND TREATMENTS. Want more information? What are the symptoms?

Alpha antagonists from initial concept to routine clinical practice

The Enlarged Prostate Symptoms, Diagnosis and Treatment

The Hallmarks of BPH Progression and Risk Factors

BPH: a present and future perspective on health impact

The patient, your co-pilot in assessing LUTS

BJUI. Worldwide prevalence estimates of lower urinary tract symptoms, overactive bladder, urinary incontinence and bladder outlet obstruction

MANAGING BENIGN PROSTATIC HYPERTROPHY IN PRIMARY CARE DR GEORGE G MATHEW CONSULTANT FAMILY PHYSICIAN FELLOW IN SEXUAL & REPRODUCTIVE HEALTH

EVALUATION OF THE EFFICACY OF TADALAFIL IN IMPROVING LOWER URINARY TRACT SYMPTOMS IN PATIENTS WITH SYMPTOMATIC BENIGN PROSTATIC ENLARGEMENT

Therapeutic Strategies for Managing BPH Progression

Management of LUTS. Simon Woodhams February 2012

Benign Prostatic Hyperplasia. Jay Lee, MD, FRCSC Clinical Associate Professor University of Calgary

A SURVEY ON LOWER URINARY TRACT SYMPTOMS (LUTS) AMONG PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA (BPH) IN HOSPITAL UNIVERSITI SAINS MALAYSIA (HUSM)

Chapter 4: Research and Future Directions

Association of BPH with OAB: The Plumbing or the Pump?

Shrestha A, Chalise PR, Sharma UK, Gyawali PR, Shrestha GK, Joshi BR. Department of Surgery, TU Teaching Hospital, Maharajgunj, Kathmandu, Nepal

Impact of Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia Treatment with Tamsulosin and Solifenacin Combination Therapy on Erectile Function

Original Article - Sexual Dysfunction

Evaluation of Sexual Dysfunction in Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia Patients

ISSN: (Print) (Online) Journal homepage:

The Evolution of Combination Therapy. US men eligible for BPH treatment * with projected population changes

RELATIONSHIPS BETWEEN AMERICAN UROLOGICAL ASSOCIATION SYMPTOM INDEX, PROSTATE VOLUME, PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA

Prostate Gland Volume and Its Relationship to Complications of Benign Prostatic Enlargement

Evaluation of Recent Trends in Treatment Patterns Among Men With Benign Prostatic Hyperplasia

Lower Urinary Tract Symptoms BPH vs OAB FLOW vs VOLUME. Matt T. Rosenberg, MD Family Practice Mid Michigan Health Centers Jackson, Michigan

Increasing Awareness, Diagnosis, and Treatment of BPH, LUTS, and EP

Lower Urinary Tract Symptoms K Kuruvilla Zachariah Associate Specialist

PROSPERO International prospective register of systematic reviews

Guideline for the primary care management of male lower urinary tract symptoms

Employers in the United States have become more cognizant

EUROPEAN UROLOGY 63 (2013)

Diagnosis and Mangement of Nocturia in Adults

All about the Prostate

Voiding Dysfunction Block lecture, 5 th year student. Choosak Pripatnanont, Department of Surgery, PSU.

Can men with prostates sized 80 ml or larger be managed conservatively?

Benign Prostatic Hyperplasia: Update on Innovative Current Treatments

Department of Urology, The University of Texas Southwestern Medical Center at Dallas, Dallas, TX

Impact of smoking on Lower Urinary Tract Symptoms (LUTS) - Single tertiary centre experience

Lower Urinary Tract Symptoms (LUTS) and Nurse-Led Clinics. Sean Diver Urology Advanced Nurse Practitioner candidate Letterkenny University Hospital

Patient Information. Lower Urinary Tract Symptoms (LUTS) and Diagnosis of BPE

As man draws near the common goal Can anything be sadder Than he who, master of his soul Is servant to his bladder LUTS 2. Prevalence of BPH LUTS 5

INJINTERNATIONAL. Sociodemographic Factors Related to Lower Urinary Tract Symptoms in Men: A Korean Community Health Survey.

Male LUT/BPH. Current Issues and Unmet Needs

During the past decade, numerous

OVER 70% OF MEN IN THEIR 60s HAVE SYMPTOMS OF BPH 1

The impact of overactive bladder on quality of life in south of China

LUTS A plea for a holistic approach. HUBERT GALLAGHER, MCh; FRCSI, FRCSI(Urol) Head of Urology Beacon Hospital

Lower UrinaryTract Symptoms (LUTS) and Sexual Function in Both Sexes

Effect of Transurethral Resection of the Prostate Based on the Degree of Obstruction Seen in Urodynamic Study

Cialis. Cialis (tadalafil) Description

REPORTS. Clinical and Economic Outcomes in Patients Treated for Enlarged Prostate

INJINTERNATIONAL. Original Article INTRODUCTION

ORIGINAL ARTICLE. Key words benign prostatic hyperplasia, bother, lower urinary tract symptoms, quality of life, tamsulosin

BPH / LUTS. Prevalence. Prevalence of BPH. It is abnormal NOT to have benign growth of the prostate with increasing age. Prevalence.

A Comparison of the Frequencies of Medical Therapies for Overactive Bladder in Men and Women: Analysis of More Than 7.2 Million Aging Patients

Office based non-oncology urology trials Richard W. Casey, MD, 1 Jack Barkin, MD 2

Questioning questions about symptoms of benign prostatic hyperplasia

L ower urinary tract symptoms (LUTS) are a major health problem and are prevalent in men aged.45 years1 3.

Treating BPH: Comparing Rezum UroLift and HoLEP

University of Bristol - Explore Bristol Research

Mr. GIT KAH ANN. Pakar Klinikal Urologi Hospital Kuala Lumpur.

김준철 가톨릭대학교의과대학비뇨기과학교실

Prevalence of Lower Urinary Tract Symptoms in Indigenous and Non-indigenous Women in Eastern Taiwan

The Journal of International Medical Research 2012; 40:

Cialis. Cialis (tadalafil) Description

Neurogenic bladder. Neurogenic bladder is a type of dysfunction of the bladder due to neurological disorder.

The potential for NX-1207 in benign prostatic hyperplasia: an update for clinicians

Combination Drug Therapy for Benign Prostatic Hyperplasia (BPH)

Sexual Dysfunction in Aging Men With Lower Urinary Tract Symptoms

Benign Prostatic Hyperplasia (BPH) Important Papers / Landmark. Vijayan Manogran

THE ACONTRACTILE BLADDER - FACT OR FICTION?

PATIENT INFORMATION 2017 NeoTract, Inc. All rights reserved. Printed in the USA. MAC Rev A

Ambulatory Try off Catheter (ATOC) Program for the Patient with Acute Retention of Urine Outpatient Service

α-blocker Monotherapy and α-blocker Plus 5-Alpha-Reductase Inhibitor Combination Treatment in Benign Prostatic Hyperplasia; 10 Years Long-Term Results

BPH: Social Impact and Patient s Perspective

PHARMACEUTICALS ISSUE 2.0 APRIL 1996 FINASTERIDE: CLINICAL AND ECONOMIC IMPACTS

Original Article. J Fac Med Baghdad 119. Nibbras I. AL-Hamdani* Ali W. Zeki*** Introduction:

Prostate Disease. Chad Baxter, MD

DOWNLOAD OR READ : TREATMENT OF BENIGN PROSTATIC HYPERPLASIA PDF EBOOK EPUB MOBI

LUTS after TURP: How come and how to manage? Matthias Oelke

A unit of International Journal Foundation Page I 96

Current drug management of BPH in primary care Claire Taylor MRCS, Charlotte Foley MRCS and Roger Kirby MA, MD, FRCS Urol

Office Management of Benign Prostatic Enlargement

Convective RF Water Vapor Energy Ablation Effectively Treats LUTS due to BPH, Preserves Erectile and Ejaculatory Function

PROSTATIC EMBOLIZATION FOR BENIGN HYPERPLASIA

The prevalence of lower urinary tract symptoms in population aged 40 years or over, in South Korea

Elements for a Public Summary

A prospective study of sexual dysfunction in patients with benign prostatic hyperplasia

Overview. Urology Dine and Learn: Erectile Dysfunction & Benign Prostatic Hyperplasia. Iain McAuley September 15, 2014

PRABHAKAR SINGH*, MANOJ INDURKAR, AMITA SINGH, PALLAVI INDURKAR

Transcription:

Male LUTS, OAB, Sex: natural history JR Sathiya

Definitions Newer concepts of LUTs Natural history of BPH Prevalence of LUTs

Definition BPH- represents a histologic diagnosis that refers to the proliferation of smooth muscle and epithelial cells within the prostatic transition zone. BPE- is defined as prostatic enlargement due to histologic benign prostatic hyperplasia. The term prostatic enlargement should be used in the absence of prostatic histology BOO- is the generic term for obstruction during voiding and is characterized by increased detrusor pressure and reduced urine flow rate.

ICS(2002) Definition of LUTS Subjective indicator of a disease or change in condition as perceived by patient, caregiver/partner and may lead him/her to seek help from health care professionals Storage symptoms include increased micturition frequency, nocturia, urinary urgency, and urinary incontinence Voiding symptoms include slow or weak stream, hesitancy, and terminal dribble Postmicturition symptoms include the sensation of incomplete emptying and postmicturition dribble

ICS Definition of OAB Urinary urgency, usually accompanied by frequency and nocturia, with or without urgency urinary incontinence, in the absence of urinary tract infection or other obvious pathology.

Newer Concepts of LUTs Previously BPH used interchangeably with LUTs. Bladder and prostate as a single functional unit. LUTs- multifactorial LUTs association with chronic disease, metabolic syndrome, sexual dysfunction

Figure 91 1. Diagram showing the relationship between histologic hyperplasia of the prostate (BPH), lower urinary tract symptoms (LUTS), benign prostate enlargement (BPE), and bladder outlet obstruction (BOO). The size of the circles does not represent actual proportions but rather illustrates the partial overlap between the different disease definitions. (From Roehrborn CG. Pathology of benign prostatic hyperplasia. Int J Impot Res 2008;20[Suppl. 3]:S11 8.) Claus G. Roehrborn- Prostatic Hyperplasia: Etiology, Pathophysiology, Epidemiology, and Natural History; Campbell-Walsh Urology 10th Edition

LUTS Storage Voiding Post- Micturition Urgency Frequency Urge Incontinence Nocturia Slow or Intermittent Stream Straining Hesitation Feeling of Incomplete Emptying Post- Micturition Dribble DO BOO Detrusor Underactivity BOO Detrusor Underactivity (Male/Female) OAB (Male) (Female) BPH Undefined (Male) (Female) BOO Undefined Drug Discovery Today: Therapeutic Strategies Figure 1. Lower urinary tract symptoms (LUTS) by type, key symptoms, underlying pathophysiology and relation to disease entity.

Risk factors of BPH/LUTs

Natural History of BPH

Natural history The natural history of a disease process refers to the prognosis of the disease over time. In other words, the measurement of changes in parameters of interest and the incidence rates of significant outcomes constitute what is commonly referred to as the natural history of a disease.

How to elucidate natural history of LUTS? Longitudinal studies of untreated cohorts of men diagnosed with LUTS and clinical BPH by any definition (watchful waiting cohorts). Studies of the behavior of men diagnosed with LUTS and BPH and enrolled in controlled studies of LUTS and BPH (control groups) and receiving: no treatment (compared with active intervention) placebo treatment (compared with medical treatment)eg PLESS, MTOPS sham treatment (compared with device or surgical treatment) Longitudinal studies of unselected (i.e., undiagnosed) men living in the community who are less likely to progress and request or require therapy (longitudinal population-based studies)-olmstead County

Problems with untreated cohorts and controlled groups Ethical issues with regards to following up symptomatic men Contact with healthcare personnel establishes bias Requirement of treatment during follow-up causes dropout from study Inclusion/Exclusion criteria renders the study population unnatural

Longitudinal population based studies Difficult to conduct Expensive Some bias remains when tests are conducted to understand the disease progression (i.e. flow rate, IPSS, prostate volume, etc) Probably the best in understanding natural history of any disease

Vol 155.595-600. February 1996 Prrnfed 111 U.S.A. NATURAL HISTORY OF PROSTATISM: LONGITUDINAL CHANGES IN VOIDING SYMPTOMS IN COMMUNITY DWELLING MEN STEVEN J. JACOBSEN," CYNTHIA J. GIRMAN, HARRY A. GUESS, THOMAS RHODES, JOSEPH E. OESTERLING AND MICHAEL M. LIEBER From th~a Departments of Health Sciences Research (Section of Clinical Epidemiology) and Urology, Mavo Clinic and Mayo Foundatcon, Rorhester, Minnesota, Merck Research Laboratories, Blue Bell, Pennsylvania, and Michigan Prostate Institute and University of Michigan, Ann Arbor, Michigan Olmsted County Study 0022-5347/95/1535-1510$03.00/0 THE JOURNAL OF UROLOGY Copyright 0 1995 by AME~lclw UROLOCICAL ASSOCIATION, INC. VOI. 153, 1510-1515, May 1995 Printed in U.S.A. NATURAL HISTORY OF PROSTATISM: RELATIONSHIP AMONG SYMPTOMS, PROSTATE VOLUME AND PEAK URINARY FLOW RATE CYNTHIA J. GIRMAN, STEVEN J. JACOBSEN, HARRY A. GUESS, JOSEPH E. OESTERLING, CHRISTOPHER G. CHUTE, LAUREL A. PANSER AND MICHAEL M. LIEBER From the Department of Epidemiology, Merck Research Laboratories, West Point, Pennsylvania, Section of Clinical Epidemiology, Health Sciences Research and Department of Urology, Mayo Clinic, Rochester, Minnesota, Departments of Epidemiology and Biostatistics, University of North Carolina, Chapel Hill, North Carolina, and Section of Urology, University of Michigan and The Michigan Prostate Institute, Ann Arbor, Michigan

Olmsted County Study The Olmsted County Study was initiated in 1990 and followed for 12 years a randomly selected cohort of 2115 men aged 40 79 years. It provides the largest body of evidence that BPH is an age-related and progressive disease.

Round 1 Round 2 Round 3 229 replacements 103 replacements 19 dead 33 dead I 95 FIG. 1. Design of Olmsted County Study of Urinary Symptoms and Health Status Among Men. FIG. 2. Movement of baseline cohort across categories of lower urinary tract symptom severity. Round 2o-mild in round 1. Round Ph-moderate to severe in round 1. Round 3c and e-mild in round 2. Round 3d and f-moderate to severe in round 2. Median interval was 18 months between rounds 1 and 2, and 42 months between rounds 1 and 3.

Olmsted County Trial At inclusion, 26% of men aged 40 49 years had moderate to severe LUTS, and this increased to 46% in men aged 70 79 years The median peak flow rate decreased from 21.2 ml/s to 14.2 ml/s in men in the respective age groups.

Olmsted County Study At the follow-up, the severity of LUTS increased and the peak flow rate decreased, with time and age TABLE 1 Changes in IPSS, peak flow rate, prostate size and cumulative incidence of serious outcomes in the Olmsted County study Variable Age, years Overall 40 49 50 59 60 69 70 Number of patients 2115 839 587 434 252 IPSS [5] Baseline, mean 6.3 5.3 6.2 7.3 7.8 Mean (SD) change/year 0.18 (1.22) 0.05 (1.06) 0.18 (1.19) 0.44 (1.35) 0.14 (1.43) Peak flow rate [4] n assessments 466 191 133 93 49 Baseline, median 21.2 21.3 16.3 14.2 Median change/year, % 2.1 1.1 2.7 2.3 6.2 Prostate volume [6] Median growth per year, % 1.9 1.9 1.9 1.8 1.6 Cumulative incidence of AUR events over 4 years, n (%) [7] 57 (2.7) 10 (1.2) 9 (1.5) 16 (3.7) 22 (8.7) Cumulative incidence of surgical procedures over 6 years [8], n (%) TURP 45 (2.1) 1 (0.1) 5 (0.9) 21 (4.8) 18 (7.1) MIST 19 (0.9) 0 6 (1.0) 7 (1.6) 6 (2.4) Total 64 (3.0) 1 (0.1) 11 (1.9) 28 (6.5) 24 (9.5) MIST, minimally invasive surgical therapies.

Olmsted County Study There was a mean increase in the AUASI/IPSS of 0.18 points per year, ranging from 0.05 in men in their forties to 0.44 in men in their sixties. The annual increase in AUASI/IPSS was low (0.14) in men aged 70 79 years, but there was no obvious reason for this. The study also showed a decrease in median peak flow rate of 2.1% per year that was also age-related, with men aged 70 years showing a more rapid decline (6.2% per year) than men in their fifties (1.1% per year).

FIGURE 2. Mean urinary flow rates measured in 2,113 men from Olmsted County, Minnesota, reveal a decrease in rates with increasing age. Adapted with permission from Girman et al. J Urol 150: 887 892, 1993. 11

Olmsted County Study The cumulative incidence of AUR was 2.7% over 4 years, ranging from 1% in men in their fifties to 9% in men aged 70 years. Overall, 3% of men had TURP or a minimally invasive surgical procedure during a 6-year followup, and this was again strongly age-related (from 0.1% in men aged 40 49 years to 9.5% in men aged 70 79 years)

) e l 0.- 10 c "1 -r-- J-r------ A 0 - s 0 0 1 2 3 4 5 6 Time from baseline questionnaire (yr) Plot of cumulative incidence of acute retention by years of followup since com letion of baseline questionnaire. Different lines represent decades orage. Solid line re resents ages 40 to 49, small dashed line ages 50 to 59, medium dasled line ages 60 to 69 and large dashed line ages 70 to 79 years.

Olmsted County Study Prostate growth also increased with time by a median of 1.9% per year. Age had little influence on prostate growth but men with large prostates at baseline had higher median growth rates (2.2% per year for prostates of >30 ml vs 1.7% per year for prostates of 30 ml). Serious outcomes, such as AUR and the need for BPH-related surgery, appeared to be low in this community-based population.

NATURAL HISTORY OF PROSTATISM -- ms % L y s n r r f m u d ~ ysn rllh 8-30 30 = 20 P c w 9 2 10 0 Am40-49 50-59 60-69 70-79 40-49 50-59 60-69 70-79 (a) 96 with peak flow rate 4 10 mlh (b) % with prostate volune > 50 ml -hatched bars represent subjects with mild or no symptoms. Single hatched bars reflect those with mod

Prevalence of Male LUTS and OAB

european urology 50 (2006) 1306 1315 available at www.sciencedirect.com journal homepage: www.europeanurology.com Incontinence EPIC Population-Based Survey of Urinary Incontinence, Overactive Bladder, and Other Lower Urinary Tract Symptoms in Five Countries: Results of the EPIC Study Debra E. Irwin a, *, Ian Milsom b, Steinar Hunskaar c, Kate Reilly d, Zoe Kopp d, Sender Herschorn e, Karin Coyne f, Con Kelleher g, Christian Hampel h, Walter Artibani i, Paul Abrams j Study available at www.sciencedirect.com journal homepage: www.europeanurology.com EUROPEAN UROLOGY 56 (2009) 14 20 Platinum Priority Voiding Dysfunction Editorial by Christopher R. Chapple on pp. 21 23 of this issue Prevalence, Severity, and Symptom Bother of Lower Urinary Tract Symptoms among Men in the EPIC Study: Impact of Overactive Bladder Debra E. Irwin a, *, Ian Milsom b, Zoe Kopp c, Paul Abrams d, Walter Artibani e, Sender Herschorn f

EPIC Study The EPIC study was a population-based, crosssectional telephone survey of 19 165 adults aged >18 yr in five countries All respondents were asked about demographics, the presence of UTI, the presence of individual LUTS using current ICS definitions, and IPSS. IPSS scores were used to assess LUTS severity: 0, none; 1 7, mild; 8 19, moderate; 20 35, severe.

EPIC Study The presence of OAB symptoms was determined by a response of yes to either of the following questions: Do you experience a sudden compelling desire to urinate which is difficult to put off?; and Do you leak urine with a sudden compelling desire to urinate? Respondents who reported UTI were excluded from this cohort

EPIC Study-Results in the General Population Among men in the general population sample (n = 7210), 62.5% reported experiencing one or more LUTS; 37.7% (ie, 60% of all men reporting any LUTS) reported experiencing only one LUTS subtype, whereas 24.8% (ie, 40% of all men reporting any LUTS) reported experiencing one or more LUTS subtype. The most commonly reported clusters of LUTS subtypes were storage plus voiding LUTS 10.8% of men had urgency (hallmark symptom of OAB)

LUTS

all men with OAB symptoms (n = 502) reported urgency; 29.3% reported only storage symptoms. Men with OAB symptoms reported a greater prevalence of multiple LUTS subtypes than men in the general population ( p < 0.05). All three LUTS subtypes were reported by 37.3% of men with OAB symptoms, 21.3% reported voiding plus storage symptoms, and 12.2% reported postmicturition plus storage symptoms OAB

The most common storage symptom was nocturia among men in the general population (48.6%;), which increased with age (p < 0.05)

Nocturia was the second most common storage symptom among men with OAB symptoms (75.3%) after urgency (100%) The prevalence of storage LUTS increased with age ( p < 0.05)

Terminal dribble (general population, 14.2%; OAB cases, 36.9%) and the sensation of incomplete emptying (general population, 13.5%; OAB cases, 36.9%)were the most frequently reported voiding and postmicturition symptoms

Among men with OAB symptoms, prevalence of voiding and postmicturition LUTS were variable with increasing age

Fig. 3 Distribution (%) of number of lower urinary tract symptoms (LUTS) by age group among (a) men in the general population (n = 7210) and (b) men in the overactive bladder (OAB) population (n = 502). The number of individual LUTS reported by each respondent increased with age ( p < 0.05), particularly among men with OAB symptoms The overall prevalence of any LUTS increased with age in the general population, from 51.3% for men <40 yr to 80.7% for men >60 yr ( p < 0.05).

Symptom severity & bother More than 6% of men in the general population reported moderate (5.4%) or severe (0.7%) LUTS, as scored by the IPSS. By contrast, almost 30% of men with OAB symptoms reported moderate (25.5%) or severe (4.4%) LUTS. For both populations, the proportional increase in men reporting any LUTS (mild, moderate, or severe) with age was significant (p<0.05). Overall, mean IPSS was nearly three times higher among men with OAB symptoms versus the general population sample

Sex

Boston Area Community Health (BACH) survey population-based random sample survey on prevalence of LUTS and association with risk factors Association with chronic diseases eg DM, hypertension, heart disease,depression Association with metabolic syndrome Association with erectile dysfunction

Relationship Between Lower Urinary Tract Symptoms and Erectile Dysfunction: Results From the Boston Area Community Health Survey Sara T. Brookes,* Carol L. Link, Jenny L. Donovan and John B. McKinlay From the Department of Social Medicine, University of Bristol, Bristol, United Kingdom and New England Research Institutes (CLL, JBM), Watertown, Massachusetts d severity by age and AUA-SI score. Moderate and severe LUTS were combined due to relatively smal

European Urology European Urology 44 (2003) 637 649 Lower UrinaryTract Symptoms and Male Sexual Dysfunction: The Multinational Survey of the Aging Male (MSAM-7) Raymond Rosen a,*, Jens Altwein b, Peter Boyle c, Roger S. Kirby d, B. Lukacs e, Eric Meuleman f, Michael P. O Leary g, Paolo Puppo h, Chris Robertson c, Francois Giuliano i Sexual activity was reported by 83% of the sample, with 71% reporting at least one episode of sexual activity during the previous 4 weeks. Sexual disorders and their bothersomeness were strongly related to both age and severity of LUTS

Base: Total sample 10 98 8.6 7.6 6.6 7 6 5 4 3 2 1 0 LUTS Severity Age Cohort 0 4.9 Mild Moderate Servere 5.7 5.7 0 4.6 3.7 4.0 3.5 Mild Moderate Servere 0 2.6 1.7 Mild Moderate Servere 50-59 years 60-69 years 70-79 years Fig. 1. Average number of sexual activities, including intercourse, per month. (a) In% 100 90 80 70 60 50 40 30 20 10 0 LUTS Severity Age Cohort 27 45 14 25 12 2 2 5 17 0 Mild Base: Total sample 50 70 53 Moderate Severe 40 33 7 0 Mild 49 43 6 Net reduction of stiffness No, I cannot get an erection 89 83 83 65 53 12 64 19 Moderate Severe 57 41 16 0 Mild 70 50 52 20 31 45 44 Moderate Severe 50-59 years 60-69 years 70-79 years